1202493-05-7 Usage
General Description
(E)-3-fluoro-N-(3,4,5-trifluorobenzylidene)aniline is a chemical compound with the molecular formula C13H7F4N. It is a fluoro-substituted aniline derivative with a benzylidene group. (E)-3-fluoro-N-(3,4,5-trifluorobenzylidene)aniline may have potential applications in the pharmaceutical industry, as it possesses interesting pharmacological properties. The presence of fluorine in its structure also makes it a valuable compound for further research and development in the field of medicinal chemistry. It can also serve as a valuable building block for the synthesis of more complex organic compounds. However, it is important to handle this chemical with care, as it may have potential health hazards and should be used in a controlled laboratory environment.
Check Digit Verification of cas no
The CAS Registry Mumber 1202493-05-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,0,2,4,9 and 3 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1202493-05:
(9*1)+(8*2)+(7*0)+(6*2)+(5*4)+(4*9)+(3*3)+(2*0)+(1*5)=107
107 % 10 = 7
So 1202493-05-7 is a valid CAS Registry Number.
1202493-05-7Relevant articles and documents
Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl carbamates as potent and long acting muscarinic antagonists
Prat, Maria,Buil, María Antonia,Fernández, Maria Dolors,Castro, Jordi,Monleón, Juan Manuel,Tort, Laia,Casals, Gaspar,Ferrer, Manuel,Huerta, Josep Maria,Espinosa, Snia,López, Manuel,Segarra, Victor,Gavald, Amadeu,Miralpeix, Montserrat,Ramos, Israel,Vilella, Dolors,González, Marisa,Córdoba, Mnica,Cárdenas, Alvaro,Antón, Francisca,Beleta, Jorge,Ryder, Hamish
scheme or table, p. 3457 - 3461 (2011/06/24)
Novel quaternary ammonium derivatives of N,N-disubstituted (3R)-quinuclidinyl carbamates have been identified as potent M3 muscarinic antagonists with long duration of action in an in vivo model of bronchoconstriction. These compounds have also presented a high level of metabolic transformation (human liver microsomes). The synthesis, structure-activity relationships and biological evaluation of these compounds are reported.
